Citation Impact
Citing Papers
Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes
2012
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
A case of bone marrow mastocytosis associated with multiple myeloma
1998
The Lymphatic System in Health and Disease
2008
Sirtuins as regulators of metabolism and healthspan
2012 Standout
Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
2012
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications
2013
Nonalcoholic fatty liver associated with impairment of kidney function in nondiabetes population.
2012
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
2012
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
The role of hepatokines in metabolism
2013
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
2011
Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia
2000
Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
2011
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Role of AID in Tumorigenesis
2007 StandoutNobel
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Fitness Versus Fatness: Moving Beyond Weight Loss in Nonalcoholic Fatty Liver Disease
2010
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings
2001
Treatment of NAFLD with diet, physical activity and exercise
2017
Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease
2011
Burden of Clostridium difficile Infection in the United States
2015 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans
2012
Niclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in mice
2014
The impact of liver fat vs visceral fat in determining categories of prediabetes
2010
Clinical and Biologic Diversity of Leukemias Occurring in Patients with Mastocytosis
2000
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Lack of Exercise Is a Major Cause of Chronic Diseases
2012 Standout
Regular Exercise Is Associated with a Reduction in the Risk of NAFLD and Decreased Liver Enzymes in Individuals with NAFLD Independent of Obesity in Korean Adults
2012
Recent Advances in Mastocytosis Research
1999
Tuberous sclerosis
2008 Standout
Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: Do androgens play a role?
2009
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy
1998
Evidence That Lymphangiomyomatosis Is Caused by TSC2 Mutations: Chromosome 16p13 Loss of Heterozygosity in Angiomyolipomas and Lymph Nodes from Women with Lymphangiomyomatosis
1998
The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function
2017 Standout
The global NAFLD epidemic
2013 Standout
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
2012
MECHANISMS IN ENDOCRINOLOGY: Are metabolically healthy obese individuals really healthy?
2014
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
2011
GASTROINTESTINAL ABNORMALITIES AND INVOLVEMENT IN SYSTEMIC MASTOCYTOSIS
2000
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Lipid-induced insulin resistance: unravelling the mechanism
2010
A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes
2015
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Type 2 diabetes mellitus
2015 Standout
Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance
2009
The AID Dilemma
2012 StandoutNobel
Diagnostic criteria and classification of mastocytosis: a consensus proposal
2001 Standout
NAFLD: A multisystem disease
2015 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Cell Biology of the Glomerular Podocyte
2003 Standout
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Epidemiology of Clostridium difficile Infection and Risk Factors for Unfavorable Clinical Outcomes: Results of a Hospital-Based Study in Barcelona, Spain
2013
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Relationships of Circulating Sex Hormone–Binding Globulin With Metabolic Traits in Humans
2010
Clostridium difficile Infection Among Children Across Diverse US Geographic Locations
2014
Tuberous Sclerosis Complex Consensus Conference: Revised Clinical Diagnostic Criteria
1998 Standout
Resolution of Fatty Liver and Risk of Incident Diabetes
2013
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Properties of Resveratrol:In VitroandIn VivoStudies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans
2015 Standout
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c‐kit mutation Asp‐816 to Val
1998
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Effect of aerobic exercise training dose on liver fat and visceral adiposity
2015
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients
2019
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
2016 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Non‐alcoholic fatty liver disease (NAFLD ) is associated with low level of physical activity: a population‐based study
2012
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Fecal Bacteriotherapy for Relapsing Clostridium difficile Infection in a Child: A Proposed Treatment Protocol
2010
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Works of S Kröber being referenced
Der Patient mit Ornithintranscarbamylasemangel
2005
Intralesional rituximab for cutaneous B-cell lymphoma
2001
Angiomyolipoma of the kidney. Immunoreactivity with HMB‐45. Light‐ and electron‐microscopic findings
1994
High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease
2008
Mastocytosis: reactive or neoplastic?
1997
Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.
1997
Lymphatic vessels in the colonic mucosa in ulcerative colitis.
2003